Business news
- Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial - The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.
- Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook - The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
- Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms - Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
- Trump refuses to be outdone by Europe, signing his own U.S.-India trade deal - The U.S. deal comes after global trading partners have been signing trade pacts, leaving America looking ostracized and more isolated.
- PepsiCo earnings beat estimates as drinks sales pick up around the world - PepsiCo reported fourth-quarter earnings and revenue that topped Wall Street's estimates.
- Palantir surges 10% after beating earnings estimates. Here's what's happening - The rise comes on the back of months of decline for the stock.
- Rare earth stocks jump after Trump launches $12 billion critical minerals stockpile - The moves come shortly after President Donald Trump announced the establishment of a U.S. critical mineral reserve.
- Elon Musk has lauded the 'social media for AI agents' platform Moltbook as a bold step for AI. Others are skeptical - Elon Musk said the platform was the "very early stages of singularity" but others are more skeptical
- Nintendo keeps its full-year sales guidance as Switch 2 momentum continues - Investors are weighing the impact of rising memory prices and the strength of Nintendo’s games pipeline ahead of the Switch 2.
- India's Nifty 50 skyrockets 5% as U.S.-India trade deal turbocharges stocks - U.S. President Donald Trump on Monday stateside said that U.S. will cut reciprocal tariff on India to 18% from 25%.